Selected [2+2+2] cycloadditions, alkene-alkyne coupling and fusion of enyne with diazo compound, all triggered by an artificial organometallic ruthenium catalyst are demonstrated to proceed under ambient aerobic aqueous conditions in presence of bodily fluids or cell lysate. To the best of our knowledge, these are the first examples of bio-and air-tolerant C-C bond formation catalyzed by an artificial organometallic compound.
conditions in complex cellular media have been reported. In this vein, the identification of organometallic processes that form C-C bonds under physiological conditions represents a particularly important challenge [9] [10] [11] .
RESULTS AND DISCUSSION
Here, we show that C-C bond formation can be performed using an artificial ruthenium organometallic catalyst in presence of aqueous aerobic media such as bodily fluids or cell lysate under mild conditions. Recently, Meggers and Streu effected the uncaging of amines from the corresponding allylcarbamates in living cells using commercially available catalyst 1 (ref. 6 ). In other work directed towards organic synthesis in bio-media, the groups of Bertozzi and Sharpless have shown alkyne functionality to be significantly biorthogonal 12, 13 . Inspired by these findings, we speculated that bio-tolerant C-C bond forming processes could be found among the rich set of known alkyne-based transformations catalyzed by 1 (ref. 14 ). We observed that [2+2+2] cycloaddition of dimethyl acetylenedicarboxylate (2) using catalyst 1 (1 mole %) 15 was not only air-tolerant 16 but also proceeded in presence of water without any added organic co-solvent (Scheme 1, 17 . Under these mild aerobic conditions, the starting material was consumed within 5.5 h and hexamethyl mellitate 3 was isolated in 76% yield. Notably, the reaction progressed to give similarly good isolated yields when performed with urine of Rattus norvegicus, cell lysate from Escherichia coli, fetal bovine serum, and human serum (entries 2-6). To the best of our knowledge, this is the first example of C-C bond formation catalyzed by an artificial organometallic compound in the presence of air and bodily fluids or cell lysate.
The study was extended to include [2+2+2] cycloaddition affording pyridine derivative 6 (Scheme 2) 16a, 18, 19 , and Alder-ene-type coupling of alkyne 7 with allyl alcohol (8) 16a,20,21 , to give a mixture of aldehydes 9 and 10 (Scheme 3). Of note is that aldehyde functionality is generated in this process. Such a feature might be further explored in the context of the follow-up reactivity profile of aldehydes in living systems 22 . Product 9 is present as a mixture of the open chain aldehyde 9a and its cyclic seven-membered hemiacetal isomer 9b (9a:9b 75:25). Interestingly, synthesis of 9 thus represents organometallic assembly of a carbon framework reminiscent of aldoheptose in a bio-relevant environment in situ.
An example of enyne-diazo compound fusion to give bicyclic cyclopropanes 13 and 14 further expands the scope of bio-tolerant transformations catalyzed by 1 (Scheme 4) 16a, 23, 24 . This transformation proceeds remarkably fast with all the media tested (E. coli cell lysate, combined yield of 13 and 14 is 60%; Rattus norvegicus urine, 57%; human serum, 45%).
Heterogeneous catalysis and transformations taking place 'on water' 5c cannot be excluded as substrates, products and also the catalyst 1 in examples in Table I conditions presented. Therefore, we next turned to a transformation where better homogeneity of the reacting mixture is ensured. Specifically, we examined the feasibility of synthesis of our novel water-soluble helical extended diquat (helquat) 25 in E. coli cell lysate with an added 1% acetone to aid solubilization of the catalyst (Scheme 5).
As judged by NMR analysis of the evaporated reaction mixture, progressive disappearance of the peaks corresponding to triyne 15 and emergence of peaks diagnostic of helquat 16 demonstrates the feasibility of this process under aerobic bio-relevant conditions (Fig. 1) . Increase in yield from 33% after 2.5 h to 51% after 36 h, demonstrates that the (C 5 Me 5 )Ru-based organometallic catalyst stays active for extended periods in this medium 26 .
Notably, the reaction proceeds effectively even in the presence of considerable amounts of bovine serum albumin, a protein known for its promiscuous binding profile (Fig. 2) 27 .
Potentially, a reaction proceeding via organometallic intermediates might be viewed as an entry to a collection of species with potential bioactivity (Fig. 3) . The possibility of searching through such species generated in situ in presence of biological targets contained in the reaction medium, might allow for investigation of binding or reactive events otherwise difficult or even impossible to realize. Such an approach seems particularly attractive in light of the fact that (C 5 H 5 )Ru and other Ru-arene organometallics have been shown to be potent and selective bioactive entities 28 . In summary, we have presented evidence that formation of C-C bonds via ruthenium organometallic catalysis can be achieved in the presence of bio-relevant media such as fetal bovine serum or E. coli cell lysate under aerobic ambient conditions. This will be of conceptual and practical interest for organometallic carbon framework construction targeted towards bio-applications including chemical biology, diagnostics, and therapeutics. Escherichia coli cell lysate. Escherichia coli DH5α transformed with plasmid pET24a (Novagen, cat. No. 69749-3) were grown in LB broth (Sigma, L3022) containing kanamycin (40 µg/ml, Fluka 60615). 40 ml of LB media were inoculated with 4 µl of saturated culture and grown overnight at 37°C and 220 rpm. The culture was spun down at 3500g for 15 min and the pellet was resuspended in 10 ml of phosphate buffered saline (PBS) and sonicated (6 × 1 min at 3-min intervals). The crude lysate was then spun down at 10000g for 30 min at 4°C and the supernatant was decanted. The solution was stored at -20°C. Before an experiment, it was thawed in a 30°C water bath. The residue content of the material was 35 mg/ml.
Fetal bovine serum (FBS). FBS was purchased from Invitrogen-Gibco (cat. No. 10270-106). Before use, FBS was heated at 65°C for 30 min to inactivate the complement system. The residue content of the material was 30 mg/ml.
Human serum. One of the authors (male, 31) donated the blood (B negative blood type). All blood analysis data were within normal range and HIV 1 + 2 negative. The serum was obtained by centrifugation of the whole blood. Serum was stored in the freezer (-20°C) and thawed before use in a 30°C bath. The residue content of the material was 100 mg/ml. Bio-and Air-Tolerant Carbon-Carbon Bond Formations the described time at room temperature (r.t.). Formation of the product and consumption of the starting material was detected by TLC (petroleum ether:ethyl acetate 50:50, product R F 0.29, starting material R F 0.85). The reaction mixture was diluted with water and extracted with ethyl acetate (5 ×). The combined organic phases were dried over anhydrous Na 2 SO 4 . The mixture was filtered and the solvent was removed in vacuo to give crude product which was purified by flash chromatography on silica gel (petroleum ether:ethyl acetate 60:40). Hexamethyl benzene-1,2,3,4,5,6-hexacarboxylate 3 was obtained as colorless crystals. The spectroscopic characterization data are in agreement with the literature 17 . Table I , entry 1. Using dimethyl acetylenedicarboxylate 2 (100 µl, 115.6 mg, 0.813 mmol, 1 equiv.), [Cp*Ru(cod)Cl] 1 (3.5 mg, 9.2 µmol, 1 mole %), water (2 ml) as the medium, and a reaction time of 5.5 h, hexamethyl benzene-1,2,3,4,5,6-hexacarboxylate 3 was obtained as colorless crystals in 76% yield (88.3 mg, 0.207 mmol). Table I , entry 6. Using dimethyl acetylenedicarboxylate 2 (100 µl, 115.6 mg, 0.813 mmol, 1 equiv.), [Cp*Ru(cod)Cl] 1 (15.6 mg, 41.1 µmol, 5 mole %), human serum (1 ml) as the medium, and a reaction time of 24 h, hexamethyl benzene-1,2,3,4,5,6-hexacarboxylate 3 was obtained as colorless crystals in 52% yield (60.2 mg, 0.141 mmol).
2-(1,3-Dihydrofuro[3,4-c]pyridin-6-yl)acetonitrile (6) Propargyl ether 4 (62 µl, 56.7 mg, 0.602 mmol, 1 equiv.) was added dropwise over 15 min via Hamilton syringe to a stirring suspension of malononitrile 5 (61.6 mg, 0.932 mmol, 1.5 equiv.) and [Cp*Ru(cod)Cl] 1 (11.4 mg, 30 µmol, 5 mole %) in fetal bovine serum (1 ml). The reaction mixture was then stirred at r.t. for 3 h. Formation of the product was detected by TLC (hexanes:ethyl acetate 50:50, R F 0.18). The reaction mixture was diluted with water and extracted with DCM (1 ×) and ethyl acetate (3 ×). The organic fractions were combined and dried over anhydrous Na 2 SO 4 . The mixture was filtered and concentrated in vacuo to yield the crude product which was purified by flash chromatography on silica gel (hexanes: ethyl acetate 40:60). 2-(1,3-Dihydrofuro[3,4-c]pyridin-6-yl)acetonitrile 6 was obtained as a colorless amorphous solid in 57% yield (55.0 mg, 0.343 mmol). The spectroscopic characterization data are in agreement with the literature 18 .
6-Hydroxy-4-methylenehexanal (9) and (E)-7-Hydroxyhept-4-enal (10) The mixture was filtered and concentrated in vacuo to give the crude product which was purified by flash chromatography on silica gel (n-pentane:diethyl ether 50:50). A 68:32 ratio of isomeric products 9 and 10 was obtained as a yellowish oil in 58% yield (39.3 mg, 0.307 mmol). Repeated chromatography allowed samples of each isomer to be isolated ( 6,7,12,13-Tetrahydro-5,14-diaza [5] helicinium Trifluoromethanesulfonate (16) Procedure to demonstrate reaction development in transformation 15 → 16. One drop of acetone (0.01 ml) was added directly to the bottom of a RBF containing [Cp*Ru(cod)Cl] 1 (1.7 mg, 4.48 µmol, 25 mole %). A solution of 2,2′-(ethyne-1,2-diyl)bis(1-(but-3-ynyl)-pyridinium)bis(trifluoromethanesulfonate) 15 (10.6 mg, 18.1 µmol, 1 equiv.) 25 in E. coli DH5α cell lysate (1.5 ml) was added to the mixture of catalyst and acetone. The resulting solution was stirred at 37°C. Aliquots (0.3 ml) of the reaction mixture were removed at reaction times of 2.5, 5, 24, and 36 h. These aliquots were concentrated in vacuo and analyzed by 1 H NMR (Fig. 1) .
Procedure for yield determination in transformation 15 → 16. One drop of acetone (0.01 ml) was added directly to the bottom of a RBF containing [Cp*Ru(cod)Cl] 1 (1.6 mg, 4.28 µmol, 25 mole %). A solution of 2,2′-(ethyne-1,2-diyl)bis(1-(but-3-ynyl)pyridinium)bis(trifluoromethanesulfonate) 15 (10.0 mg, 17.1 µmol, 1 equiv.) 25 in E. coli DH5α cell lysate (1.5 ml) was added to the mixture of catalyst and acetone. The resulting solution was stirred at 37°C 25 and bovine serum albumin (26.4 mg) in E. coli DH5α cell lysate (1 ml) was added to the mixture of catalyst and acetone. The resulting solution was stirred at 37°C for 36 h. The reaction mixture was concentrated in vacuo. 1 H NMR analysis indicates formation of 6,7,12,13-tetrahydro-5,14-diaza- [5] helicinium trifluoromethanesulfonate 16 and consumption of the starting material 15 (Fig. 2) .
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